Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dyslipidemias | 3 | 2012 | 235 | 0.810 |
Why?
|
| Coronary Disease | 3 | 2016 | 675 | 0.660 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2016 | 730 | 0.570 |
Why?
|
| Nasopharyngitis | 1 | 2016 | 5 | 0.530 |
Why?
|
| Pruritus | 1 | 2016 | 41 | 0.520 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 230 | 0.440 |
Why?
|
| Anticholesteremic Agents | 1 | 2016 | 235 | 0.440 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 274 | 0.430 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 300 | 0.390 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1026 | 0.350 |
Why?
|
| Influenza, Human | 1 | 2016 | 662 | 0.330 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 570 | 0.310 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 431 | 0.270 |
Why?
|
| Lipids | 1 | 2010 | 522 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 1271 | 0.200 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2016 | 73 | 0.130 |
Why?
|
| Angina, Unstable | 1 | 2016 | 52 | 0.130 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2016 | 69 | 0.130 |
Why?
|
| Back Pain | 1 | 2016 | 28 | 0.130 |
Why?
|
| Ezetimibe | 1 | 2016 | 94 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1961 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 214 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 509 | 0.100 |
Why?
|
| Medical Records | 1 | 2012 | 191 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1118 | 0.090 |
Why?
|
| Comorbidity | 1 | 2016 | 1528 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 1269 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 359 | 0.090 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 295 | 0.090 |
Why?
|
| Triglycerides | 1 | 2012 | 576 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 375 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 1043 | 0.080 |
Why?
|
| Stroke | 1 | 2016 | 976 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2006 | 13 | 0.070 |
Why?
|
| Aged | 2 | 2016 | 19711 | 0.070 |
Why?
|
| Acute Disease | 1 | 2010 | 1096 | 0.070 |
Why?
|
| Prevalence | 1 | 2012 | 2466 | 0.060 |
Why?
|
| Recurrence | 1 | 2010 | 1394 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 630 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1187 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 183 | 0.060 |
Why?
|
| Middle Aged | 2 | 2016 | 26741 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3403 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 3431 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 1172 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1104 | 0.050 |
Why?
|
| Biomarkers | 1 | 2010 | 3102 | 0.040 |
Why?
|
| Humans | 4 | 2016 | 125309 | 0.040 |
Why?
|
| United States | 1 | 2012 | 10907 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 16360 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2010 | 12282 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 10296 | 0.020 |
Why?
|
| Male | 1 | 2012 | 61531 | 0.020 |
Why?
|
| Female | 1 | 2012 | 66791 | 0.020 |
Why?
|